Key result
The apoA1 -75G>A SNP was not associated with recurrent coronary events overall (HR 1.37; 95% CI 0.95-1.97; p=0.09), but increased risk in Black patients (HR 2.40; 95% CI 1.07-5.40; p=0.034).
Why the study?
Data regarding the relationship between the apoA1 -75G>A polymorphism with apoA1 levels and risk of coronary artery disease are inconsistent, particularly across ethnicities.
Does the apoA1 -75G>A SNP increase the risk of recurrent coronary events in Black and White post-myocardial infarction patients?
Cohort (n=834)
Does the apoA1 -75G>A SNP increase the risk of recurrent coronary events in Black and White post-myocardial infarction patients?
Hazard Ratio: 1.37 (95% CI 0.95–1.97)
p-value: p=0.09
The apoA1 -75G>A polymorphism is a significant risk factor for recurrent coronary events in Black, but not White, patients following a myocardial infarction.
No overall association with recurrent events but possible higher risk in Black patients; leaves open ancestry-specific effects pending validation.
Since data regarding the relationship between a common polymorphism (SNP) of the apoA1 gene with apoA1 levels and risk of coronary artery disease are inconsistent, we hypothesized that its association with recurrent coronary events differs for White and Black individuals with diagnosed coronary heart disease. The apoA1 -75G>A SNP was genotyped in a cohort of 834 Black (n=129) and White (n=705) post-myocardial infarction patients. Recurrent coronary events (coronary-related death, non-fatal myocardial infarction, or unstable angina) were documented during an average follow-up of 28 months. Thirty percent of White and 21% of Black patients carried the SNP. Cox proportional-hazards regression analysis, adjusting for clinical and laboratory covariates, demonstrated that the SNP was not associated with recurrent events in the total cohort (HR=1.37, 95% CI 0.95-1.97; p= 0.09) but was the only variable associated with an increased risk of recurrent cardiac events in Blacks (HR=2.40, 95% CI 1.07-5.40; p= 0.034). Conversely in Whites, the SNP was not associated with recurrent events (HR=1.12, 95% CI 0.75-1.67; p= 0.59) whereas apoB (HR=1.78, 95% CI 1.20 -2.65; p= 0.0042) and calcium channel blocker use (HR=2.53, 95% CI 1.72-3.72; p<0.001) were associated; p= 0.0024 for interaction between ethnicity and the SNP. A common apoA1 SNP is associated with a significantly increased risk of recurrent cardiac events among Black, but not White, postmyocardial infarction patients. Relationships with lipoproteins may help explain this finding.
No takes yet. Share an insight, caveat, or question.
Block et al. (2009) conducted a cohort in post-myocardial infarction (n=834). apoA1 -75G>A SNP vs. non-carriers was evaluated on Recurrent coronary events (coronary-related death, non-fatal myocardial infarction, or unstable angina) (HR 1.37, 95% CI 0.95-1.97, p=0.09). The apoA1 -75G>A SNP was not associated with recurrent coronary events overall (HR 1.37; 95% CI 0.95-1.97; p=0.09), but increased risk in Black patients (HR 2.40; 95% CI 1.07-5.40; p=0.034).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: